Low Risk of Skin and Nipple Sensitivity and Lactation Issues

Total Page:16

File Type:pdf, Size:1020Kb

Low Risk of Skin and Nipple Sensitivity and Lactation Issues Breast Surgery Aesthetic Surgery Journal 2016, Vol 36(6) 672–680 Low Risk of Skin and Nipple Sensitivity and © 2016 The American Society for Aesthetic Plastic Surgery, Inc. This is an Open Access article Lactation Issues After Primary Breast distributed under the terms of the Creative Commons Attribution- Augmentation with Form-Stable Silicone NonCommercial-NoDerivs licence (http://creativecommons.org/ Implants: Follow-Up in 4927 Subjects licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that Herluf G. Lund, MD, FACS; Janet Turkle, MD; Mark L. Jewell, MD; the work is properly cited. For commercial re-use, please contact and Diane K. Murphy, MBA [email protected]. DOI: 10.1093/asj/sjv266 www.aestheticsurgeryjournal.com Abstract Background: Natrelle 410 implants (Allergan, Inc., Irvine, CA) are approved in the United States for breast augmentation, reconstruction, and revision. Objectives: To assess the risk of nipple and skin sensation changes and lactation issues in subjects receiving implants for primary breast augmentation and ascertain whether differences based on incision site exist. Methods: We used 410 Continued Access study data to assess safety and effectiveness of devices implanted via inframammary or periareolar incision sites. Subjects were evaluated preoperatively and at 4 weeks, 6 months, and annually up to 10 years postoperatively. Lactation issues and nipple and skin sensation changes (hypersensitivity/paresthesia, loss of sensation) were assessed. Results: The inframammary and periareolar cohorts comprised 9217 and 610 implanted devices, with mean follow-up of 4.1 years (range, 0-10.1 years) and 4.8 years (range, 0-10.1 years), respectively. In the inframammary cohort, risk of first occurrence of nipple sensation changes was 0.3% (95% CI: 0.2-0.5) at week 4 and month 6, and 0.4% (0.3-0.7) at year 10. Risk of skin sensation changes was 0.0% (95% CI: 0.0-0.2) at week 4, 0.1% (0.0-0.2) at month 6, and 0.1% (0.0-0.3) at all subsequent time points. No nipple or skin changes occurred in the periareolar cohort. Incidence of lactation issues was similar to that reported in postpartum women who did not have breast implants. Conclusions: We found that the risk of nipple or skin sensation changes and lactation issues is low and provide long-term safety and effectiveness data on subjects receiving implants for primary breast augmentation. Level of Evidence: 3 Accepted for publication December 1, 2015; online publish-ahead-of-print April 26, 2016. Therapeutic Breast augmentation is among the most common cosmetic Dr Lund is a plastic surgeon in private practice in Chesterfield, MO. surgery procedures worldwide, with approximately 287,000 Dr Turkle is a plastic surgeon in private practice in Carmel, IN. 1 procedures performed in the United States alone in 2014. Dr Jewell is a plastic surgeon in private practice in Eugene, OR. Silicone gel-filled implants have been used for breast aug- Ms Murphy is the Director of Clinical Development at Allergan plc, mentation for more than 50 years.2 Implant characteristics Irvine, CA. have changed greatly during that time, from having limited Corresponding Author: available sizes (ie, volume), shapes, and textures to having Dr Herluf G. Lund, St. Louis Cosmetic Surgery, 17300 N Outer 40 Road, a variety of dimensional and silicone gel-filled styles. Over #300, Chesterfield, MO 63005, USA. the years, surgical methodology and operational techniques E-mail: [email protected] Lund et al 673 have evolved from an experiential approach to analytical or aplasia. All subjects were required to have adequate tissue quantitative measurement.3,4 available to cover the implants and be willing to follow all While rates of certain adverse events, such as capsular study requirements. contracture, are well documented for many implant types,5 other potential complications of breast implants are not as Data Analysis well documented. Specifically, a limited number of articles Subjects were evaluated pre- and postoperatively at 0 to have reported on the potential effect of breast implants on 4 weeks, 6 months, and annually for up to 10 years following nipple or skin sensitivity and on lactation in women undergo- primary implant surgery. Written case report forms (CRFs) ing primary breast augmentation. This study reports on the were used for data collection in this study; investigators re- risk of nipple and skin sensation changes and lactation issues viewed and signed the CRFs and carried the ultimate re- in subjects receiving Natrelle 410 breast implants (Allergan sponsibility for the accuracy and completeness of the data plc, Dublin, Ireland) for primary breast augmentation. provided. Nipple hypersensitivity/paresthesia or loss of nipple sensation changes and skin hypersensitivity/paresthe- METHODS sia or loss of skin sensation changes were captured prospec- tively on a complications CRF. Data on severity, treatment, Study Design and resolution status were collected. Those reported as mod- This analysis, based on data collected through July 31 2014, erate, severe, or very severe, but not as mild or very mild, in the 410 Continued Access study, assessed the safety and were counted. Overall nipple and skin sensation changes effectiveness of Natrelle 410 implant devices. Natrelle 410 were compiled from the data collected on the CRF. Risk breast implants are form-stable, teardrop-shaped devices of first occurrence of overall nipple sensation changes (ie, filled with a highly cohesive silicone gel.3 Each implant style nipple hypersensitivity/paresthesia plus loss of nipple sensa- has a Biocell (Allergan plc, Dublin, Ireland) textured shell tion) was calculated; risk of first occurrence, resolution surface with irregularly spaced depressions and a mean pore status, and time to resolution were also calculated for individ- diameter of 300 µm (range, 100-600 µm).6-8 Natrelle 410 ual variables (nipple hypersensitivity/paresthesia and loss of breast implants were approved by the US Food and Drug nipple sensation). Similarly, risk of first occurrence of overall Administration in 2013.9,10 Long-term safety, effectiveness, skin sensation changes was calculated; risk of first occur- and subject satisfaction are supported by results from a rence, resolution status, and time to resolution were also 10 year, multicenter prospective study.11 calculated for individual variables (skin hypersensitivity/ Devices were implanted by surgeons certified by the paresthesia and loss of skin sensation). For subjects experi- American Board of Plastic Surgery with experience placing encing nipple or skin sensation changes, time to resolution silicone-filled implants; investigators were required to have was reported for those with resolution. participated in the pivotal study.11 The study was conducted Some subjects became pregnant following implantation in compliance with the US Food and Drug Administration re- and opted to breastfeed their babies. Lactation issues were quirements.12 Before enrolling subjects, an institutional review assessed before and after implantation as reported on the board (IRB) at each site approved the study protocol (the full medical history or follow-up CRF, as applicable. Information list of approving IRBs is available online as Supplementary collected included whether breastfeeding was attempted, material, at www.aestheticsurgeryjournal.com). All subjects the number of children for whom breastfeeding was attempt- provided written informed consent before surgery. ed, the number of children who were successfully breastfed, and any lactation problems that occurred. Lactation prob- lems were defined as inadequate milk production, excessive Subjects milk production, mastitis, pain, and “other.” Device assess- ments at year 8 were conducted by asking physicians if the The 410 Continued Access study enrolled female subjects shape of the breast reflected the shape of the implant (yes or aged 18 years or older, presenting for primary breast aug- no) and if the breast implant maintained its original position mentation, primary breast reconstruction, or breast implant (yes or no). revision surgery. Inclusion and exclusion criteria were identical to those previously detailed in the published pivotal Statistical Analysis study.13 Here, we report results for subjects exclusively undergoing primary breast augmentation who underwent Kaplan-Meier analyses of the rates of sensation problems surgical implantation of devices via inframammary or periar- were performed to assess the risk of first occurrence of the eolar incision sites, the two most common surgical approach- development of changes in nipple and skin sensation. The es in clinical practice.14 Eligible subjects aged 18 years or cumulative risk ratio and its 95% confidence interval (CI) older underwent primary breast augmentation because of were calculated for assessments of risk. No hypothesis tests dissatisfaction with breast size or shape, asymmetry, ptosis, of predictors were performed because of the low incidence 674 Aesthetic Surgery Journal 36(6) Table 1. Baseline Demographics and Characteristics Table 1. (Continued) Characteristic Inframammary Periareolar Characteristic Inframammary Periareolar Incision Incision Incision Incision Primary augmentation cohort Not provided 10 (0.2) 0 (0.0) Number of subjects 4621 306 Lactation sub-cohort Age, years, median (range) 36 (18-72) 36 (18-82) Number of subjects 294b 19 Body mass index, kg/m2 Age, years, median (range) 28 (18-52) 32 (26-46) Median (range) 20.8 (15.4-47.0) 21.7 (16.5-40.4) Pregnancies/live births in subjects with 145 7 no prior pregnancies Race,a no. (%) Pregnancies/live births in subjects with 159 12 White 4121 (88.9) 260 (83.6) prior pregnancies Asian 215 (4.6) 11 (3.5) aSubjects were allowed to select more than one response. bIn the inframammary subgroup, 294 subjects attempted breastfeeding after 304 pregnancies. Hispanic 125 (2.7) 18 (5.8) Black 51 (1.1) 6 (1.9) of occurrences. Descriptive statistics were used in all other analyses. Other 47 (1.0) 7 (2.3) Not provided 74 (1.6) 9 (2.9) RESULTS Marital status,a no.
Recommended publications
  • Breast-Reconstruction-For-Deformities
    ASPS Recommended Insurance Coverage Criteria for Third-Party Payers Breast Reconstruction for Deformities Unrelated to AMERICAN SOCIETY OF PLASTIC SURGEONS Cancer Treatment BACKGROUND Burn of breast: For women, the function of the breast, aside from the brief periods when it ■ Late effect of burns of other specified sites 906.8 serves for lactation, is an organ of female sexual identity. The female ■ Acquired absence of breast V45.71 breast is a major component of a woman’s self image and is important to her psychological sense of femininity and sexuality. Both men and women TREATMENT with abnormal breast structure(s) often suffer from a severe negative A variety of reconstruction techniques are available to accommodate a impact on their self esteem, which may adversely affect his or her well- wide range of breast defects. The technique(s) selected are dependent on being. the nature of the defect, the patient’s individual circumstances and the surgeon’s judgment. When developing the surgical plan, the surgeon must Breast deformities unrelated to cancer treatment occur in both men and correct underlying deficiencies as well as take into consideration the goal women and may present either bilaterally or unilaterally. These of achieving bilateral symmetry. Depending on the individual patient deformities result from congenital anomalies, trauma, disease, or mal- circumstances, surgery on the contralateral breast may be necessary to development. Because breast deformities often result in abnormally achieve symmetry. Surgical procedures on the opposite breast may asymmetrical breasts, surgery of the contralateral breast, as well as the include reduction mammaplasty and mastopexy with or without affected breast, may be required to achieve symmetry.
    [Show full text]
  • Análise De Receptores Hormonais De Estrógeno E Progesterona Em
    NUBERTO HOPFGARTNER TEIXEIRA Análise de receptores hormonais de estrógeno e progesterona em hipertrofia mamária versus normomastia, avaliação de presença e densidade com uma nova proposta de classificação das hipertrofias mamárias Tese apresentada à Faculdade de Medicina da Universidade de São Paulo para obtenção do Título de Doutor em Ciências Programa de Clínica Cirúrgica Orientador: Prof. Dr. Marcio Paulino Costa São Paulo 2019 Autorizo a reprodução e divulgação total ou parcial deste trabalho, por qualquer meio convencional ou eletrônico, para fins de estudo e pesquisa, desde que citada a fonte. Dedico esta tese A minha esposa Vivian. Ao meu filho Henri. Ao meu falecido pai que me modelou para vida. À minha mãe que sempre se mostrou uma batalhadora. AGRADECIMENTOS Agradeço ao meu orientador Prof. Dr. Marcio Paulino Costa e ao Departamento de Patologia nas pessoas dos patologistas: Evelin Sanchez, Profa. Dra. Sheila Siqueira e Prof. Dr. Venâncio Avancini Ferreira Alves, os quais possibilitaram esta tese e cujas análises me permitiram concluir. Aos pacientes que concederam suas mamas para participação deste estudo. Ao Prof. Dr. Rolf Gemperli, Professor Titular da Disciplina de Cirurgia Plástica. “A tarefa não é tanto ver aquilo que ninguém viu, mas pensar o que ninguém ainda pensou sobre aquilo que todo mundo vê”. Arthur Schopenhauer NORMALIZAÇÃO ADOTADA Esta tese está de acordo com as seguintes normas, em vigor no momento desta publicação: Referências: adaptado de International Committee of Medical Journals Editors (Vancouver). Universidade de São Paulo. Faculdade de Medicina. Divisão de Biblioteca e Documentação. Guia de apresentação de dissertações, teses e monografias. Elaborado por Anneliese Carneiro da Cunha, Maria Julia de A.
    [Show full text]
  • Low Risk of Skin and Nipple Sensitivity and Lactation Issues
    Breast Surgery Aesthetic Surgery Journal 2016, Vol 36(6) 672–680 Low Risk of Skin and Nipple Sensitivity and © 2016 The American Society for Aesthetic Plastic Surgery, Inc. This is an Open Access article Lactation Issues After Primary Breast distributed under the terms of the Creative Commons Attribution- Augmentation with Form-Stable Silicone NonCommercial-NoDerivs licence (http://creativecommons.org/ Implants: Follow-Up in 4927 Subjects licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that Herluf G. Lund, MD, FACS; Janet Turkle, MD; Mark L. Jewell, MD; the work is properly cited. For commercial re-use, please contact and Diane K. Murphy, MBA [email protected]. DOI: 10.1093/asj/sjv266 Downloaded from www.aestheticsurgeryjournal.com Abstract http://asj.oxfordjournals.org/ Background: Natrelle 410 implants (Allergan, Inc., Irvine, CA) are approved in the United States for breast augmentation, reconstruction, and revision. Objectives: To assess the risk of nipple and skin sensation changes and lactation issues in subjects receiving implants for primary breast augmentation and ascertain whether differences based on incision site exist. Methods: We used 410 Continued Access study data to assess safety and effectiveness of devices implanted via inframammary or periareolar incision sites. Subjects were evaluated preoperatively and at 4 weeks, 6 months, and annually up to 10 years postoperatively. Lactation issues and nipple and skin sensation changes (hypersensitivity/paresthesia, loss of sensation) were assessed. Results: The inframammary and periareolar cohorts comprised 9217 and 610 implanted devices, with mean follow-up of 4.1 years (range, 0-10.1 years) and 4.8 years (range, 0-10.1 years), respectively.
    [Show full text]
  • ISAPS Global Survey Results 2018
    ISAPS INTERNATIONAL SURVEY ON AESTHETIC/COSMETIC PROCEDURES performed in 2018 CONTENTS About ISAPS ..................................................................................................................page 3 Surgical Totals Ranked by Category ...............................................................page 29 About the International Survey on Nonsurgical Totals Ranked by Category .......................................................page 30 Aesthetic/Cosmetic Procedures ..........................................................................page 4 Countries Ranked by Total Number of Procedures ................................page 31 Countries Ranked by Estimated HIGHLIGHTS OF THE 2018 STATISTICS Number of Plastic Surgeons .............................................................................page 32 2018 Statistics at a Glance .......................................................................................pages 6-7 Surgical Procedure Group Ranking by Country ........................................page 33 Nonsurgical Procedure Group Ranking by Country ................................page 34 NUMBER OF WORLDWIDE PROCEDURES PROCEDURES PERFORMED BY PLASTIC SURGEONS Number of Worldwide Surgical Procedures ...............................................page 9 Number of Worldwide Surgical Procedures Number of Worldwide Nonsurgical Procedures .........................................page 10 Performed by Plastic Surgeons ........................................................................page 36 Surgical Procedures
    [Show full text]
  • Cirugía De La Mama
    25,5 mm 15 GUÍAS CLÍNICAS DE LA ASOCIACIÓN ESPAÑOLA DE CIRUJANOS 15 CIRUGÍA DE LA MAMA Fernando Domínguez Cunchillos Sapiña Juan Blas Ballester Parga Gonzalo de Castro Fernando Domínguez Cunchillos Juan Blas Ballester Sapiña Gonzalo de Castro Parga CIRUGÍA DE LA MAMA CIRUGÍA SECCIÓN DE PATOLOGÍA DE LA MAMA Portada AEC Cirugia de la mama.indd 1 17/10/17 17:47 Guías Clínicas de la Asociación Española de Cirujanos CIRUGÍA DE LA MAMA EDITORES Fernando Domínguez Cunchillos Juan Blas Ballester Sapiña Gonzalo de Castro Parga SECCIÓN DE PATOLOGÍA DE LA MAMA © Copyright 2017. Fernando Domínguez Cunchillos, Juan Blas Ballester Sapiña, Gonzalo de Castro Parga. © Copyright 2017. Asociación Española de Cirujanos. © Copyright 2017. Arán Ediciones, S.L. Castelló, 128, 1.º - 28006 Madrid e-mail: [email protected] http://www.grupoaran.com Reservados todos los derechos. Esta publicación no puede ser reproducida o transmitida, total o parcialmente, por cualquier medio, electrónico o mecánico, ni por fotocopia, grabación u otro sistema de reproducción de información sin el permiso por escrito de los titulares del Copyright. El contenido de este libro es responsabilidad exclusiva de los autores. La Editorial declina toda responsabilidad sobre el mismo. ISBN 1.ª Edición: 978-84-95913-97-5 ISBN 2.ª Edición: 978-84-17046-18-7 Depósito Legal: M-27661-2017 Impreso en España Printed in Spain CIRUGÍA DE LA MAMA EDITORES F. Domínguez Cunchillos J. B. Ballester Sapiña G. de Castro Parga AUTORES A. Abascal Amo M. Fraile Vasallo B. Acea Nebril G. Freiría Barreiro J. Aguilar Jiménez C. A. Fuster Diana L.
    [Show full text]
  • Incidence of Breast and Nipple Abnormalities Among Primigravid Women in Sri Lanka
    Original Articles Incidence of breast and nipple abnormalities among primigravid women in Sri Lanka Sujeewa Amarasena 1 Sri Lanka Journal of Child Health , 2006; 35 : 51-4 (Key words: incidence, breast and nipple abnormalities, primigravid women, Sri Lanka) Abstract breast 4, unilateral or bilateral absence of breast Objective To determine the incidence of breast and (amastia) and tubular breast deformity 1. These are nipple abnormalities among primigravid women and well-recognized causes of lactation failure. Some their effects on lactation in Sri Lanka. abnormalities are correctable with antenatal interventions. One study identified the incidence of Design Prospective descriptive survey. inverted or nonprotractile nipples resulting in attachment difficulties to be 10% among 1926 Method All primigravid women attending antenatal nulliparous women 5. Incidence of these abnormalities clinics of the university obstetric unit, giving and their correctability among Sri Lankan women is informed consent, were recruited into the study. Their not known. breasts were examined clinically and breast abnormalities noted. They were followed up until Objectives successful lactation was established. 1. To assess the incidence of breast and nipple Results 956 mothers were examined. 768 had normal abnormalities among primigravid women breasts and 188 abnormalities were noted. 725 attending antenatal clinics in Sri Lanka. completed the study. 72.5% established successful lactation. 80 had flat nipples of whom 52 completed 2. To assess the correctability of flat or inverted the study. 44 flat nipples were corrected antenatally nipples with Hoffman 4 exercises. with exercises. All established lactation successfully. Other abnormalities included breast surgery, 3. To assess the effects of antenatal interventions hypoplastic breasts or breast asymmetry.
    [Show full text]
  • Breast Augmentation Using Preexpansion and Autologous Fat Transplantation: a Clinical Radiographic Study
    COSMETIC Breast Augmentation Using Preexpansion and Autologous Fat Transplantation: A Clinical Radiographic Study Daniel A. Del Vecchio, Background: Despite the increased popularity of fat grafting of the breasts, M.D., M.B.A. there remain unanswered questions. There is currently no standard for tech- Louis P. Bucky, M.D. nique or data regarding long-term volume maintenance with this procedure. Boston, Mass.; and Philadelphia, Pa. Because of the sensitive nature of breast tissue, there is a need for radiographic evaluation, focusing on volume maintenance and on tissue viability. This study was designed to quantify the long-term volume maintenance of mature adi- pocyte fat grafting for breast augmentation using recipient-site preexpansion. Methods: This is a prospective examination of 25 patients in 46 breasts treated with fat grafting for breast augmentation from 2007 to 2009. Indications in- cluded micromastia, postexplantation deformity, tuberous breast deformity, and Poland syndrome. Preexpansion using the BRAVA device was used in all patients. Fat was processed using low–g-force centrifugation. Patients had pre- operative and 6-month postoperative three-dimensional volumetric imaging and/or magnetic resonance imaging to quantify breast volume. Results: All women had a significant increase in breast volume (range, 60 to 200 percent) at 6 months, as determined by magnetic resonance imaging (n ϭ 12), and all had breasts that were soft and natural in appearance and feel. Magnetic resonance imaging examinations postoperatively revealed no new oil cysts or breast masses. Conclusions: Preexpansion of the breast allows for megavolume (Ͼ300 cc) grafting with reproducible, long-lasting results that can be achieved in less than 2 hours.
    [Show full text]
  • Breast Augmentation Historic Plagues BOARD of DIRECTORS
    NEWS OFFICIAL NEWS OF THE INTERNATIONAL SOCIETY OF AESTHETIC PLASTIC SURGERY 2 14 | Volume Number 2 Number INSIDE New Webinar Series Global Perspectives: Breast Augmentation Historic Plagues BOARD OF DIRECTORS PRESIDENT Dirk Richter, MD, PhD Wesseling, GERMANY [email protected] PRESIDENT-ELECT Nazim Cerkes, MD, PhD Istanbul, TURKEY [email protected] FIRST VICE PRESIDENT Lina Triana, MD Cali, COLOMBIA [email protected] SECOND VICE PRESIDENT Gianluca Campiglio, MD, PhD Milan, ITALY [email protected] THIRD VICE PRESIDENT Arturo Ramirez-Montanana, MD Monterrey, MEXICO NO. [email protected] VOLUME 14 SECRETARY 2 Ivar van Heijningen, MD Knokke-Heist, BELGIUM [email protected] TREASURER Kai-Uwe Schlaudraff, MD, FEBOPRAS Geneva, SWITZERLAND CONTENTS [email protected] HISTORIAN Peter Scott, MD Message from the Editor 3 Johannesburg, SOUTH AFRICA [email protected] Message from the President 4 PARLIAMENTARIAN Tim Papadopoulos, MD Education Council Update 7 Sydney, AUSTRALIA [email protected] Visiting Professor Program 8 EDUCATION COUNCIL CHAIR Managing during COVID-19 10 Vakis Kontoes, MD, PhD Athens, GREECE ISAPS Insurance 17 [email protected] Obituaries 18 EDUCATION COUNCIL VICE CHAIR Ozan Sozer, MD El Paso, Texas, US Journal Update 20 [email protected] Global Sponsor Feature 21 NATIONAL SECRETARIES CHAIR Michel Rouif, MD Global Perspectives 23 Tours, FRANCE [email protected] Case Study 69 PAST PRESIDENT Renato Saltz MD, FACS Surgical Marking 75 Salt Lake City, Utah,
    [Show full text]
  • What You Should Know Before Having a Breast Augmentation
    Updated, January 2017 Since the first silicone breast implant surgery was performed on a young Texas housewife in 1962, millions of women have opted to do the same. In an interview with The Daily Mail, Jean Lindsey recounts how she agreed to be a guinea pig for this study as a way to attract more attention from the opposite sex. Newly divorced and raising six children, the 26-year old rarely got asked out on dates. But as soon as the bandages were off, men were doing double takes as she passed them on the street. Her experience paved the way for generations of women to come. What You Should Know Before Having a Breast Augmentation Breast augmentation – also known as augmentation mammoplasty – is a surgical procedure that can be used to correct the size, shape, symmetry, and other aspects of a woman’s breasts. It’s the most popular cosmetic surgical procedure in the U.S., with 305,856 procedures performed in 2015, according to the American Society of Aesthetic Plastic Surgery (ASAPS). However, that number is likely to be even higher since the member-reported survey does not include augmentations performed by surgeons that are not board certified. There are several reasons why this procedure is so popular. Breast augmentations are often performed for medical reasons, such as micromastia (underdeveloped breasts), mastectomy (removing breast tissue), and significant asymmetry (most women have one breast that is larger than the other), but they’re more often done for emotional or aesthetic reasons. Breast implants can replace volume and fullness after weight loss or pregnancy (hello, mommy makeover!), or can be used as a tool to boost confidence.
    [Show full text]
  • Benign Disease of the Breast
    25 Benign Disease of the Breast Eva J. Kantelhardt INTRODUCTION Table 1 Differential diagnosis of benign breast lesions A variety of conditions may occur in the breast. Benign condition Key findings Starting from congenital abnormalities, conditions due to hormonal changes throughout reproductive Fibroadenoma Firm tumor in the breast, life and physiological differences due to pregnancy well-defined, mobile (‘breast mouse’) and lactation are known. There may also be infec- Fibrocystic changes Consolidated area, rather diffuse tions and proliferative diseases. Women with breast Cyst On ultrasound black, round area problems will present at all ages. with defined margins The most important issue is to bear in mind that a Mastitis Signs of infection patient complaining of breast symptoms can have Papilloma Unilateral bloody nipple discharge breast cancer as well as a benign condition. When Hormonal imbalance Bilateral clear or milky nipple breast cancer is not treated early, median survival will discharge be around 3 years. With early diagnosis and treat- Mastodynia Recurrent breast pain associated ment, the woman has a good chance of being cured. with menstrual cycle This chapter deals with benign breast disease; Chapter 30 describes breast cancer diagnosis and treatment in detail (see Table 1 for differential diag- nosis). It is important to understand that breast is very important to collect as much information as cancer can mimic even benign disease, especially poss ible prior to the definite surgical treatment as benign solid tumors. the approach to surgery in malignant and benign Both benign and malignant breast disorders can disease differs. With inadequate surgery you may present with: a palpable mass; skin dimpling, thick- worsen the chances of your patient being cured.
    [Show full text]
  • Breast Deformities and Mastopexy
    CME Breast Deformities and Mastopexy Maurice Y. Nahabedian, Learning Objections: After reviewing this article, the participant should be able M.D. to: 1. Appreciate the diversity of approaches for the correction of breast de- Washington, D.C. formities and mastopexy. 2. Review the salient literature. 3. Understand patient selection criteria and indications. Summary: Breast deformities and mastopexy continue to challenge plastic sur- geons. Deformities such as Poland syndrome, tuberous breast, gynecomastia, and other congenital conditions are uncommon; therefore, management ex- perience is often limited. Various techniques have been described, with no general consensus regarding optimal management. Mastopexy has become more common and is performed both with and without augmentation mam- maplasty. However, a variety of techniques are available, and a thorough un- derstanding of the indications, patient selection criteria, and techniques is important to optimize outcomes. This article will review these and other con- ditions to provide a better understanding of the current available data and evidence for these operations. (Plast. Reconstr. Surg. 127: 91e, 2011.) hen considering all types of breast sur- TUBEROUS BREAST DEFORMITY gery, the category of breast deformity is There are several features of the tuberous Wperhaps the least prevalent and in some breast that are important to identify before man- ways the most challenging. The conditions that agement. These include a constricted base, con- make up this category include tuberous breast, traction of the skin envelope, relative micromastia, Poland syndrome, and gynecomastia, as well as enlarged diameter of the nipple-areola complex, congenital and developmental breast asymme- and herniation of breast parenchyma through the tries.
    [Show full text]
  • The Adolescent Breast Donald E
    University of Kentucky UKnowledge Pediatrics Faculty Publications Pediatrics 2012 The Adolescent Breast Donald E. Greydanus Michigan State University Stephanie Stockburger University of Kentucky, [email protected] Hatim A. Omar University of Kentucky, [email protected] Right click to open a feedback form in a new tab to let us know how this document benefits oy u. Follow this and additional works at: https://uknowledge.uky.edu/pediatrics_facpub Part of the Pediatrics Commons Repository Citation Greydanus, Donald E.; Stockburger, Stephanie; and Omar, Hatim A., "The Adolescent Breast" (2012). Pediatrics Faculty Publications. 103. https://uknowledge.uky.edu/pediatrics_facpub/103 This Book Chapter is brought to you for free and open access by the Pediatrics at UKnowledge. It has been accepted for inclusion in Pediatrics Faculty Publications by an authorized administrator of UKnowledge. For more information, please contact [email protected]. The Adolescent Breast Notes/Citation Information Published in Adolescent Medicine: Pharmacotherapeutics in General, Mental and Sexual Health. Donald E. Greydanus, Dilip R. Patel, Hatim A. Omar, Cynthia Feucht, & Joav Merrick, (Eds.). p. 285-299. ©2012 Walter de Greyter GmbH & Co. KG, Berlin, Boston The opc yright holder has granted permission for posting the chapter here. Reprinted as an article in International Journal of Child and Adolescent Health, v. 5, no. 4, p. 345-355. Reprinted as a book chapter in Child and Adolescent Health Yearbook 2012. Joav Merrick, (Ed.). p. 399-414. This book chapter is available at UKnowledge: https://uknowledge.uky.edu/pediatrics_facpub/103 adolescent breast ld E. Creydanus, Stephanie Stockburger, and Hatim A. Omar is an important organ system for the adolescent female and occasionally for lescent male as well.
    [Show full text]